Clinical trial Recruiting at 2 sites Observational Ages 0 Days to 9 Months

Tregs and miRNAs in Breast Milk: See if breast milk miRNAs influence infant immune cells and food tolerance

Official title: Immunoregulatory Factors in Human Breast Milk: Relationship Between Regulatory T Cells (Tregs), miRNAs and Food Tolerance

Run by Istanbul University · NCT07744373 · Data updated 2026-11-12

This observational study tests whether immune-regulating miRNAs in breast milk relate to the development of infant food tolerance via regulatory T cells.

More Immune Tolerance trials

Quick facts

Study typeObservational
Ages0 Days to 9 Months
SexAll
Enrollment25 (estimated)
SponsorIstanbul University
Academic / other
Locations2 sites (Istanbul and 1 other locations)
StatusRecruiting
StartedOctober 1, 2025
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2026
Registry record updatedAugust 4, 2026
Trial IDNCT07744373 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are lactating mothers and their term-born infants up to 9 months old who are exclusively breastfed for the first 6 months and consent to serial milk sampling.

Probably not a fit

Premature infants, non-exclusively breastfed infants, or those with major congenital or chronic illnesses may not derive direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective study will collect breast milk at several postnatal time points (colostrum, days 10-15, and months 1, 4, 6, and/or 9) and a single infant blood sample at 6-9 months to explore miRNAs associated with regulatory T cells. Researchers will analyze breast milk and infant blood for regulatory T cell–related miRNAs and their target genes, and will relate these findings to the infant’s food tolerance development. Laboratory work will include RNA isolation from milk, molecular analyses, and immunologic/cytometric assessments, performed under standardized sample handling. The study aims to identify temporal patterns of miRNA expression and potential links to immune regulation and food tolerance outcomes.

Why it matters

Potential benefit: If successful, findings could improve understanding of how breast milk components influence infant immune development and food tolerance.

How similar studies have gone: Previous work has shown breast milk miRNAs can modulate immune development in infants, but this study explores specific Treg-related miRNAs and longitudinal patterns in relation to food tolerance.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Lactating mothers and their infants attending the Child Health and Diseases Clinic at Istanbul University Faculty of Medicine, or the Child Health and Diseases Clinic at Esencan Hospital.
2. Infants who are exclusively breastfed for the first 6 months.
3. Mothers willing to provide breast milk samples at multiple time points (colostrum, transitional milk, and mature milk at 1, 4, 6, and/or 9 months postpartum).
4. Infants aged 0-9 months, born at term (≥37 weeks gestation) with no major congenital anomalies or chronic illnesses.
5. Mothers and infants who provide informed consent for participation in the study.

Exclusion Criteria:

1. Infants who are not exclusively breastfed for the first 6 months.
2. Infants with chronic illnesses or diagnosed immunodeficiency, metabolic, or gastrointestinal disorders.
3. Mothers who are unable or unwilling to provide informed consent.
4. Mothers with chronic illnesses or immunological disorders that may affect breast milk composition.

Where it's running

  • Child Health and Diseases Clinic, Esencan Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting
  • İstanbul University İstanbul Medical Faculty Department of Pediatrics Division of Social Pediatrics
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.